Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;119(1-2):75-82.
doi: 10.1016/j.ymgme.2016.07.002. Epub 2016 Jul 15.

221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative

Kristi Bentler  1 , Shaohui Zhai  2 , Sara A Elsbecker  3 , Georgianne L Arnold  4 , Barbara K Burton  5 , Jerry Vockley  4 , Cynthia A Cameron  2 , Sally J Hiner  2 , Mathew J Edick  2 , Susan A Berry  6 ; Inborn Errors of Metabolism Collaborative
Collaborators, Affiliations

221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative

Kristi Bentler et al. Mol Genet Metab. 2016 Sep.

Abstract

Introduction: There is limited understanding of relationships between genotype, phenotype and other conditions contributing to health in neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) identified through newborn screening.

Methods: Retrospective analysis of comprehensive data from a cohort of 221 newborn-screened subjects identified as affected with MCADD in the Inborn Errors of Metabolism - Information System (IBEM-IS), a long term follow-up database of the Inborn Errors of Metabolism Collaborative, was performed.

Results: The average age at notification of first newborn screen results to primary care or metabolic providers was 7.45days. The average octanoylcarnitine (C8) value on first newborn screen was 11.2μmol/L (median 8.6, range 0.36-43.91). A higher C8 level correlated with an earlier first subspecialty visit. Subjects with low birth weight had significantly lower C8 values. Significantly higher C8 values were found in symptomatic newborns, in newborns with abnormal lab testing in addition to newborn screening and/or diagnostic tests, and in subjects homozygous for the c.985A>G ACADM gene mutation or compound heterozygous for the c.985A>G mutation and deletions or other known highly deleterious mutations. Subjects with neonatal symptoms, or neonatal abnormal labs, or neonatal triggers were more likely to have at least one copy of the severe c.985A>G ACADM gene mutation. C8 and genotype category were significant predictors of the likelihood of having neonatal symptoms. Neonates with select triggers were more likely to have symptoms and laboratory abnormalities.

Conclusions: This collaborative study is the first in the United States to describe health associations of a large cohort of newborn-screened neonates identified as affected with MCADD. The IBEM-IS has utility as a platform to better understand the characteristics of individuals with newborn-screened conditions and their follow-up interactions with the health system.

Keywords: ACADM; Inborn error of metabolism; MCAD; Medium-chain acyl-coenzyme A dehydrogenase deficiency; Newborn screening; Octanoylcarnitine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
C8 comparisons by genotype category
See this image and copyright information in PMC

References

    1. Feuchtbaum L, Carter J, Dowray S, Currier RJ, Lorey F. Birth prevalence of disorders detectable through newborn screening by race/ethnicity. Genet Med. 2012 Nov;14(11):937–45. doi: 10.1038/gim.2012.76. - DOI - PubMed
    1. Matern D, Rinaldo P. Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet] Seattle (WA): University of Washington, Seattle; 2000. Apr 20, [updated 2015 Mar 5] 1993–2016. Available from http://www.ncbi.nlm.nih.gov/books/NBK1424/ - PubMed
    1. Wilson CJ, Champion MP, Collins JE, Clayton PT, Leonard JV. Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis. Arch Dis Child. 1999 May;80(5):459–62. - PMC - PubMed
    1. Andresen BS, Lund AM, Hougaard DM, et al. MCAD deficiency in Denmark. Mol Genet Metab. 2012 Jun;106(2):175–88. doi: 10.1016/j.ymgme.2012.03.018. - DOI - PubMed
    1. U.S. Department of Health and Human Services Advisory Committee on Heritable Disorders in Newborns and Children. Recommended Uniform Screening Panel. www.hhs.gov. [Online] [Cited: Mar. 25, 2016] http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/r....

Publication types

Substances

Supplementary concepts